Nicholas J. Hellenthal

Roswell Park Comprehensive Cancer Center

Papers

6

Total Citations

434

H-Index

5

About

Nicholas J. Hellenthal is a leading urologic oncologist whose research has fundamentally shaped the modern surgical management of bladder cancer, particularly through the advancement of robot-assisted radical cystectomy (RARC). As a key contributor to the International Robotic Cystectomy Consortium (IRCC), his work has provided the largest, multi-institutional evidence base for this minimally invasive approach. His landmark studies, each cited over 100 times, critically evaluated surgical margins and lymphadenectomy outcomes, demonstrating that RARC could achieve oncologic standards comparable to open surgery. Hellenthal’s research also addressed the critical "learning curve" effect, showing that patient outcomes are not compromised during a surgeon’s initial experience, and standardized the reporting of post-operative morbidity. By systematically analyzing data from hundreds of cases across multiple centers, he helped validate RARC as a safe, effective alternative, directly influencing clinical guidelines and training protocols worldwide. His contributions have been instrumental in transitioning bladder cancer surgery into the robotic era, improving recovery for countless patients.

Research Focus

Key Achievements

5
H-Index
6
Papers
434
Total Citations
72
Avg Citations/Paper
🏆 Most Cited Paper
Surgical Margin Status After Robot Assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium
112 citations · 2010
📈 Most Prolific Year: 2010 (5 Papers)
🤝 Key Collaborators: 49
🏛 Institutions: Roswell Park Comprehensive Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago